XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
 Additional Paid-In Capital
 Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   54,929,973      
Beginning balance at Dec. 31, 2022 $ 1,179.3 $ 5.5 $ 658.5 $ 610.7 $ (95.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (12.2)     (12.2)  
Other comprehensive income (loss), net of tax 22.0       22.0
Dividends paid (44.5)     (44.5)  
Restricted stock issuances, net (in shares)   21,927      
Stock options exercised (in shares)   813      
Stock-based employee compensation expense 6.7   6.7    
Stock issued to directors as compensation (in shares)   6,726      
Stock issued to directors as compensation 0.5   0.5    
Purchases and retirement of common stock (in shares)   (118,779)      
Purchases and retirement of common stock (2.8)     (2.8)  
Ending balance (in shares) at Jun. 30, 2023   54,840,660      
Ending balance at Jun. 30, 2023 1,149.0 $ 5.5 665.7 551.2 (73.4)
Beginning balance (in shares) at Mar. 31, 2023   54,919,923      
Beginning balance at Mar. 31, 2023 1,159.3 $ 5.5 662.4 579.3 (87.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4.5)     (4.5)  
Other comprehensive income (loss), net of tax 14.5       14.5
Dividends paid (22.1)     (22.1)  
Restricted stock issuances, net (in shares)   (18,237)      
Stock-based employee compensation expense 3.0   3.0    
Stock issued to directors as compensation (in shares)   3,318      
Stock issued to directors as compensation 0.3   0.3    
Purchases and retirement of common stock (in shares)   (64,344)      
Purchases and retirement of common stock (1.5)     (1.5)  
Ending balance (in shares) at Jun. 30, 2023   54,840,660      
Ending balance at Jun. 30, 2023 $ 1,149.0 $ 5.5 665.7 551.2 (73.4)
Beginning balance (in shares) at Dec. 31, 2023 54,211,124 54,211,124      
Beginning balance at Dec. 31, 2023 $ 949.1 $ 5.4 669.6 235.0 39.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (29.4)     (29.4)  
Other comprehensive income (loss), net of tax (10.8)       (10.8)
Dividends paid (11.0)     (11.0)  
Restricted stock issuances, net (in shares)   104,320      
Stock-based employee compensation expense [1] 0.3   0.3    
Stock issued to directors as compensation (in shares)   8,741      
Stock issued to directors as compensation 0.5   0.5    
Purchases and retirement of common stock $ (0.7)   (0.7)    
Ending balance (in shares) at Jun. 30, 2024 54,324,185 54,324,185      
Ending balance at Jun. 30, 2024 $ 898.0 $ 5.4 669.7 194.6 28.3
Beginning balance (in shares) at Mar. 31, 2024   54,311,255      
Beginning balance at Mar. 31, 2024 906.9 $ 5.4 667.3 201.6 32.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1.4)     (1.4)  
Other comprehensive income (loss), net of tax (4.3)       (4.3)
Dividends paid (5.6)     (5.6)  
Restricted stock issuances, net (in shares)   9,132      
Stock-based employee compensation expense [1] 2.2   2.2    
Stock issued to directors as compensation (in shares)   3,798      
Stock issued to directors as compensation $ 0.2   0.2    
Ending balance (in shares) at Jun. 30, 2024 54,324,185 54,324,185      
Ending balance at Jun. 30, 2024 $ 898.0 $ 5.4 $ 669.7 $ 194.6 $ 28.3
[1]
(1)Includes the impact of the equity-to-liability modification of certain restricted stock awards.